Fully bioresorbable vascular scaffolds (BVS) are a new approach to the percutaneous treatment of coronary artery disease. The BVS have not yet been fully tested in complex lesions, including chronic total occlusion (CTO). We report a CTO case successfully treated with a second-generation bioabsorbable drug-eluting scaffold.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108739 | PMC |
http://dx.doi.org/10.5114/pwki.2014.43521 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!